Previous Next

2024-04-03

Triglyceride-glucose index and chest pain

Endocrinology and Metabolism

The triglyceride-glucose index is a simple marker of insulin resistance, linked to cardiovascular disease. In this study, researchers evaluated the association between this index, chest pain and all-cause mortality in patients with and without chest pain. The data showed a positive correlation between the triglyceride-glucose index and chest pain, even after adjusting for potential confounding factors. For each one-unit increase in the index, the RR for mortality was 1.14 for participants with chest pain and 1.25 for those without. A linear relationship was observed between the index and chest pain. 

Source(s) :
Yao Zhao et al. Associations of triglyceride-glucose (TyG) index with chest pain incidence and mortality among the U.S. population. Cardiovasc Diabetol. 2024 Mar 30;23(1):111. ;

Last press reviews


Darolutamide, undetectable PSA, and prolonged survival: a new standard in prostate cancer treatment?

By Lila Rouland | Published on November 12, 2025 | 3 min read<br>

Darolutamide: Will it redefine the initial treatment strategy in metastatic prostate cancer?

By Lila Rouland | Published on November 12, 2025 | 4 min read<br>